Edwards Lifesciences Corporation Treasury Stock, Common, Value
Edwards Lifesciences Corporation (EW) had Treasury Stock, Common, Value of $7.67 billion as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:TreasuryStockCommonValue · last filed 2026-08-04
- 2026-06-30: Treasury Stock, Common, Value $7.67B.
- 2026-03-31: Treasury Stock, Common, Value $7.51B.
- 2025-12-31: Treasury Stock, Common, Value $7.09B.
- 2025-09-30: Treasury Stock, Common, Value $7.05B.
| Period end | Treasury Stock, Common, Value |
|---|---|
| 2026-06-30 | $7.67B 10-Q · filed 2026-08-04 |
| 2026-03-31 | $7.51B 10-Q · filed 2026-05-06 |
| 2025-12-31 | $7.09B 10-Q · filed 2026-08-04 |
| 2025-09-30 | $7.05B 10-Q · filed 2025-11-05 |
| 2025-06-30 | $6.46B 10-Q · filed 2025-08-06 |
| 2025-03-31 | $6.45B 10-Q · filed 2025-05-06 |
| 2024-12-31 | $6.19B 10-K · filed 2026-02-25 |
| 2024-09-30 | $6.09B 10-Q · filed 2024-11-06 |
| 2024-06-30 | $5.18B 10-Q · filed 2024-07-31 |
| 2024-03-31 | $5.02B 10-Q · filed 2024-04-29 |
| 2023-12-31 | $5.02B 10-K · filed 2025-02-28 |
| 2023-09-30 | $4.58B 10-Q · filed 2023-10-27 |
| 2023-06-30 | $4.40B 10-Q · filed 2023-07-28 |
| 2023-03-31 | $4.39B 10-Q · filed 2023-04-28 |
| 2022-12-31 | $4.14B 10-K · filed 2024-02-12 |
| 2022-09-30 | $3.28B 10-Q · filed 2022-10-28 |
| 2021-12-31 | $2.42B 10-K · filed 2023-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |